AgomAb Therapeutics NV American Depositary Shares

Market Cap

$563M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$9.92-$6.08 (-38.00%)

Jun 5, 2026

52W High $16.2152W Low $9.85

Company Details

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases in the United States. The company's product pipeline includes Ontunisertib (AGMB-129), a...

CEO

—

IPO Date

Feb 6, 2026

Website

www.agomab.com

Key Metrics TTM (EUR)

Revenue

- YoY

Net Income

-€12M

EPS (Diluted)

Free Cash Flow

-€13M

Revenue / Share

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

Apr 27, 2026

FY 2025

Dec 31, 2025

€0

Q4 2025

Dec 31, 2025

€0

FY 2024

Dec 31, 2024

€0

Q4 2024

Dec 31, 2024

€0

Revenue & Profitability (EUR)

Operating Cash Flow (EUR)

CapEx Spend (EUR)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (EUR)

OpEx Breakdown (EUR)

War Chest (EUR)

Shares Outstanding